Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.3
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2022   175,530,212    
Beginning balance at Dec. 31, 2022 $ 661,103,391 $ 175,530 $ 775,241,114 $ (114,313,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock vested (in shares)   659,479    
Restricted stock vested 0 $ 659 (659)  
Shares to cover tax withholding for restricted stock vested (in shares)   (79,634)    
Shares to cover tax withholdings for restricted stock vested 0 $ (79) 79  
Induced exercise of common warrants issued in offering (in shares)   4,517,427    
Induced exercise of common warrants issued in offering 3,613,941 $ 4,517 3,609,424  
Payments to cover tax withholdings for restricted stock vested, net (134,381)   (134,381)  
Share-based compensation 1,943,696   1,943,696  
Net income 32,715,779     32,715,779
Ending balance (in shares) at Mar. 31, 2023   180,627,484    
Ending balance at Mar. 31, 2023 699,242,426 $ 180,627 780,659,273 (81,597,474)
Beginning balance (in shares) at Dec. 31, 2022   175,530,212    
Beginning balance at Dec. 31, 2022 661,103,391 $ 175,530 775,241,114 (114,313,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 53,968,162      
Ending balance (in shares) at Sep. 30, 2023   195,380,527    
Ending balance at Sep. 30, 2023 733,453,527 $ 195,380 793,603,238 (60,345,091)
Beginning balance (in shares) at Mar. 31, 2023   180,627,484    
Beginning balance at Mar. 31, 2023 699,242,426 $ 180,627 780,659,273 (81,597,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock vested (in shares)   288,709    
Restricted stock vested 0 $ 289 (289)  
Shares to cover tax withholding for restricted stock vested (in shares)   (77,687)    
Shares to cover tax withholdings for restricted stock vested 0 $ (78) 78  
Induced exercise of common warrants issued in offering (in shares)   14,512,166    
Induced exercise of common warrants issued in offering 8,687,655 $ 14,512 8,673,143  
Payments to cover tax withholdings for restricted stock vested, net (141,682)   (141,682)  
Share-based compensation 2,260,312   2,260,312  
Net income 28,791,605     28,791,605
Ending balance (in shares) at Jun. 30, 2023   195,350,672    
Ending balance at Jun. 30, 2023 738,840,316 $ 195,350 791,450,835 (52,805,869)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock vested (in shares)   39,443    
Restricted stock vested 0 $ 39 (39)  
Shares to cover tax withholding for restricted stock vested (in shares)   (9,588)    
Shares to cover tax withholdings for restricted stock vested 0 $ (9) 9  
Payments to cover tax withholdings for restricted stock vested, net (18,302)   (18,302)  
Share-based compensation 2,170,735   2,170,735  
Net income (7,539,222)     (7,539,222)
Ending balance (in shares) at Sep. 30, 2023   195,380,527    
Ending balance at Sep. 30, 2023 733,453,527 $ 195,380 793,603,238 (60,345,091)
Beginning balance (in shares) at Dec. 31, 2023   196,837,001    
Beginning balance at Dec. 31, 2023 786,582,900 $ 196,837 795,834,675 (9,448,612)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock vested (in shares)   1,342,112    
Restricted stock vested 0 $ 1,342 (1,342)  
Shares to cover tax withholding for restricted stock vested (in shares)   (244,911)    
Shares to cover tax withholdings for restricted stock vested 0 $ (245) 245  
Payments to cover tax withholdings for restricted stock vested, net (814,985)   (814,985)  
Share-based compensation 1,723,832   1,723,832  
Net income 5,515,377     5,515,377
Ending balance (in shares) at Mar. 31, 2024   197,934,202    
Ending balance at Mar. 31, 2024 793,007,124 $ 197,934 796,742,425 (3,933,235)
Beginning balance (in shares) at Dec. 31, 2023   196,837,001    
Beginning balance at Dec. 31, 2023 786,582,900 $ 196,837 795,834,675 (9,448,612)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 61,812,795      
Ending balance (in shares) at Sep. 30, 2024   198,196,034    
Ending balance at Sep. 30, 2024 851,310,143 $ 198,196 798,747,764 52,364,183
Beginning balance (in shares) at Mar. 31, 2024   197,934,202    
Beginning balance at Mar. 31, 2024 793,007,124 $ 197,934 796,742,425 (3,933,235)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock vested (in shares)   303,797    
Restricted stock vested 0 $ 304 (304)  
Shares to cover tax withholding for restricted stock vested (in shares)   (71,702)    
Shares to cover tax withholdings for restricted stock vested 0 $ (72) 72  
Payments to cover tax withholdings for restricted stock vested, net (86,991)   (86,991)  
Share-based compensation 2,077,778   2,077,778  
Net income 22,418,994     22,418,994
Ending balance (in shares) at Jun. 30, 2024   198,166,297    
Ending balance at Jun. 30, 2024 817,416,905 $ 198,166 798,732,980 18,485,759
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock vested (in shares)   39,442    
Restricted stock vested 0 $ 39 (39)  
Shares to cover tax withholding for restricted stock vested (in shares)   (9,705)    
Shares to cover tax withholdings for restricted stock vested 0 $ (9) 9  
Payments to cover tax withholdings for restricted stock vested, net (17,273)   (17,273)  
Share-based compensation 32,087   32,087  
Net income 33,878,424     33,878,424
Ending balance (in shares) at Sep. 30, 2024   198,196,034    
Ending balance at Sep. 30, 2024 $ 851,310,143 $ 198,196 $ 798,747,764 $ 52,364,183